Drugs / Botulinium Toxin-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07523477 | Jun 2025 → Dec 2026 expected | detrusor sphincter dyssynergia, nocturnal enuresis | Tanta University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Botulinium Toxin-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07523477 ↗ |
| Known as | BTX-A | “botulinum toxin A (BTX-A) injection” NCT07523477 ↗ |
| Action | Inhibit | “inhibit the release of a number of neurotransmitters” NCT07523477 ↗ |